Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV
Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV
Chromis is developing an innovative pipeline of therapeutics to cure chronic HBV
Cure for
Chronic Hepatitis B
400 Million People Suffer from
Chronic HBV Infection
HBV is the leading cause of cancer-related morbidity and mortality worldwide
HBV is the leading cause of cancer-related morbidity and mortality worldwide
HBV is the leading cause of cancer-related
morbidity and mortality worldwide
400 Million People Suffer from
Chronic HBV Infection
About Chronic
HBV Infection
HBV is the leading cause of cancer-related morbidity and mortality worldwide
CHR101
By disrupting the HBV lifecycle, our lead drug candidate
has the potential to eradicate
chronic HBV infection
By disrupting the HBV lifecycle, our lead drug candidate has the potential to eradicate chronic HBV infection
By disrupting the HBV life cycle,
our lead drug candidate has the
potential to eradicate chronic HBV infection
CHR101
